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Abstract
The mitochondrial free radical theory of aging (mFRTA) implicates Reactive Oxygen Species (ROS)-induced mutations of
mitochondrial DNA (mtDNA) as a major cause of aging. However, fifty years after its inception, several of its premises are
intensely debated. Much of this uncertainty is due to the large range of values in the reported experimental data, for
example on oxidative damage and mutational burden in mtDNA. This is in part due to limitations with available
measurement technologies. Here we show that sample preparations in some assays necessitating high dilution of DNA
(single molecule level) may introduce significant statistical variability. Adding to this complexity is the intrinsically stochastic
nature of cellular processes, which manifests in cells from the same tissue harboring varying mutation load. In conjunction,
these random elements make the determination of the underlying mutation dynamics extremely challenging. Our in silico
stochastic study reveals the effect of coupling the experimental variability and the intrinsic stochasticity of aging process in
some of the reported experimental data. We also show that the stochastic nature of a de novo point mutation generated
during embryonic development is a major contributor of different mutation burdens in the individuals of mouse
population. Analysis of simulation results leads to several new insights on the relevance of mutation stochasticity in the
context of dividing tissues and the plausibility of ROS ’’vicious cycle’’ hypothesis.
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Introduction
Mitochondria are the main energy producing organelles present
in eukaryotic cells. Mitochondria are the only organelles aside
from the nucleus which harbor their own genetic material.
Mitochondrial DNA (mtDNA) encodes a small number of
polypeptides needed for the electron transfer chain (ETC). The
ETC is responsible for cellular energy synthesis via oxidative
phosphorylation (OXPHOS), during which some of the electrons
leak from the ETC and are captured by oxygen to form reactive
oxygen species (ROS) [1]. Most ROS are detoxified by cellular
antioxidant defenses, but some escape and cause damage to
cellular biomolecules like lipids, protein and nucleic acids [2].
Mitochondrial DNA may be particularly susceptible to such
oxidative insult due to its proximity to the ROS production sites of
the ETC [3]. Oxidative damage of mtDNA and its implications on
cellular aging form the basis of the mitochondrial Free Radical
Theory of Aging (mFRTA) [3]. One of the predictions of the
mFRTA is the possibility of ROS ‘vicious cycle’ (Figure 1),
referring to the hypothesized positive feedback mechanism in
which mtDNA mutations cause an increase in the ROS
production resulting in a higher de novo mutation rate [3]. Major
challenges and questions with respect to the mFRTA have been
summarized in some of the recent reviews [4,5].
Despite uncertainties related to the assumptions of mFRTA, the
importance of mitochondria as both the source and target of ROS
in aging is supported by some transgenic mouse studies. For
example, a 15% increase in the maximum and median lifespan is
observed in knock-in mice expressing human catalase, an enzyme
that decomposes H2O2 into water and oxygen, in mitochondria
(MCAT), but not in the nucleus or the peroxisome [6].
Furthermore, MCAT mice heart tissue accumulates less than
50% of the mtDNA point mutations of age-matched wild-type
mice [7]. Also, studies of homozygous knock-in mice with an error-
prone polymerase-c (POLG mutator mice) show that a dramatic
increase in mtDNA mutation burden, most importantly deletions
[7], is associated with shortened lifespan and some phenotypes that
may resemble accelerated human-like aging [8,9].
Although there is reasonable evidence for an age-dependent
increase in mtDNA mutations, the dynamics by which these
mutations accumulate is still largely unclear. Inferring dynamics
and more importantly, the mechanism by which mtDNA
mutations accumulate critically depends on accurate quantifica-
tion of oxidative and mutational burden, which poses significant
experimental challenges [4]. Many of these challenges stem from
the limitations associated with experimental protocols in measur-
ing oxidative damages and mutational frequency [10,11], which
typically exist at extremely low magnitude. Consequently,
published reports show conflicting results regarding the levels of
oxidative damages and mutation dynamics of mtDNA during
aging [12–14]. A highly sensitive method based on the random
mutation capture (RMC) assay has recently been developed for the
quantification of mtDNA mutation frequency [15]. This method is
based on restriction enzyme digestion and amplification of
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recognition site [12]. Application to wild-type mice has revealed
mtDNA mutation burdens that were two orders of magnitude
lower than previously determined using PCR-cloning and
sequencing protocols [8,9]. This indicates that PCR artifacts
may have been a major contributor of errors in the past reports.
Furthermore, quantification of age-dependent accumulation of
point mutation burdens using the RMC assay in wild-type mice
suggested an exponential increase, apparently supporting the
existence of a ‘vicious cycle’ in the mutation accumulation [3,13].
However, the low levels of burden suggest that point mutations
may not be a major determinant of lifespan [12] and it is difficult
to see how a positive feedback mechanism could set in at such a
miniscule level of point mutation burden.
One requirement for addressing these uncertainties is a better
understanding of the inherent stochasticity of cellular processes
[16]. The accumulation of mtDNA mutations likely involves
complex stochastic factors, such as the inherent random nature of
mutations and related cellular processes in the context of aging.
For instance, enzyme staining for ETC deficient tissue of
substantia nigra neurons in aged subjects and Parkinson patients
revealed a high degree of mosaicity of COX respiratory deficient
cells [17]. This mosaicity has also been seen in skeletal muscle cells
associated with sarcopenia in aged subjects [18]. Also, studies on
Caenorhabditis elegans indicate that individual worms and their cells
harbor a wide spectrum of mtDNA deletion loads [19].
Here we aim to address these challenges using a systems
approach by way of constructing mathematical models that
encompass the most relevant biological processes and also features
related to experimental protocols to comprehend the origin and
consequence of mutation variability that arises in individuals of a
mouse population. Additionally, we seek to better understand the
influence of intrinsic stochasticity of the mutation process on the
variability observed in the experimental data. Such understanding
may reveal possible causes of disagreements amongst published
reports and further facilitate optimization of experimental design.
In this study, we have constructed an in silico stochastic mouse
model using the Chemical Master Equation (CME) [20]. Here, the
accumulation of point mutations in mtDNA is simulated to arise as
a consequence of what we believe to be a minimal process required
for the maintenance of mtDNA integrity.
Methods
In silico mouse model
The in silico mouse model accounts for the accumulation of
mtDNA point mutations across two stages of mouse life:
development and postnatal (Figure 2). In this study, the number
of wild-type mtDNA (W) and mutant mtDNA (M) molecules are
tracked for each cell in whole mouse heart (,2.5610
7 cells) and
liver tissues (,4610
8 cells) [21]. Each mutant mtDNA molecule
is assumed to contain only a single mutation in the TaqI
recognition site (TCGA), following the RMC experimental
design [12]. The probability of finding two or more mutations
at the same site is negligible [15]. The model simulates two
mtDNA-related maintenance processes: mitochondrial turnover,
comprising of relaxed replication and degradation of mitochon-
dria, and de novo point mutation, based on a minimal conservative
assumptions. First, the mtDNA population of each cell is assumed
to exist as a well-mixed pool due to fast fusion and fission
dynamics of mitochondria [22]. Second, due to the low overall
mutation burden, point mutation burden is assumed to remain
below the level of functional significance (i.e. no nuclear
retrograde signaling [23,24]). While the latter assumption is
conservative, our simulations indicate that the incorporation of
functional effects of mutations into the model, by assuming that
mutant mtDNA are non-functional and cells respond to a
decrease in the number of wild-type (WT) mtDNA by increasing
replication, does not result in any significant changes to the
mutation burden (see Text S1 and Figure S3). A Langevin
Figure 1. Mitochondrial ROS vicious cycle. A putative positive
feedback mechanism between mtDNA and ROS is based on the
hypothesis that ROS-induced damaged mtDNA produce defective
components of the ETC, thereby increasing electron leakage in the
OXPHOS process and ROS production. The vicious cycle is expected to
give an exponential expansion of mtDNA mutations over time, which
eventually causes the loss of mitochondrial function in generating ATP.
doi:10.1371/journal.pcbi.1000572.g001
Author Summary
Aging is characterized by a systemic decline of an
organism’s capacity in responding to internal and external
stresses, leading to increased mortality. The mitochondrial
Free Radical Theory of Aging (mFRTA) attributes this
decline to the accumulation of damages, in the form of
mitochondrial DNA (mtDNA) mutations, caused by free
radical byproducts of metabolism. However, there is still a
great deal of uncertainty with this theory due to the
difficulties in quantifying mtDNA mutation burden. In this
modeling study, we have shown that a random drift in
mtDNA point mutation during life, in combination with the
experimental sampling can explain the variability seen in
some of the reported experimental data. Particularly, we
found that while the average mutation increases in a linear
fashion, the variability in the mutation load data increases
over time, and thus a low number of data replicates can
often lead to a deceptive inference of the mutation burden
dynamics. The model also predicted a significant contri-
bution from the embryonic developmental phase to the
accumulation of mtDNA mutation burden. Furthermore,
the model revealed that the replication rate of mtDNA is a
major determinant of new mutations during development
and in fast-dividing tissues.
Stochastic Drift in mtDNA Point Mutations
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that stochastic drift can lead to a clonal expansion of mtDNA
mutations in human [25].
Following experimental evidence, each mitochondrion is
assumed to carry 10 mtDNA molecules and these mtDNA are
assumed to undergo replication and degradation due to mito-
chondrial turnover [26]. In a turnover event (Figure 2B), ten
molecules of mtDNA are chosen randomly from a well mixed
population of mtDNA in a cell and are either degraded or
replicated according to the CME described below. The selection of
ten wild-type and mutant mtDNA molecules from the population
can be described as a hypergeometric random sampling following
the probability distribution: [27]
fx ðÞ ~
W
x
  
M
10{x
  
WzM
10
   ð1Þ
Figure 2. Stochastic mouse mtDNA model. (A) The in silico mouse model simulates the point mutation load of mtDNA in cells of a tissue such as
heart and liver during development and postnatal stages. (B) Stochastic drift of point mutations in cells results as a consequence of mtDNA
maintenance processes. Three sources of randomness are captured: (I) a random selection of a mitochondrion with ten mtDNA molecules from a
well-mixed population, (II) a random replication or degradation of a mitochondrion, and (III) random occurrences of de novo mtDNA point mutation
during replication.
doi:10.1371/journal.pcbi.1000572.g002
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replication or degradation.
De novo point mutation can occur during replication of mtDNA
due to mis-pairing associated with ROS-induced mutagenic
lesions such as 8-hydroxy-2-deoxyguanosine (8OHdG) [2] or as
random errors arising due to finite polymerase-c (POLG) fidelity
[28]. Consequently, each replication of a wild-type mtDNA has a
finite probability, given by the mutation rate constant (km), to
produce a mutant. Here, the number of de novo mutant mtDNA is
randomly chosen from a binomial distribution: [27]
gy ðÞ ~
x
y
  
:ky
m: 1{km ðÞ
x{y ð2Þ
where y denotes the number of de novo mutations resulting from
replication of x wild-type mtDNA.
Based on these probabilities, the in silico mouse model is
formulated as a CME in which each mtDNA-related process:
replication without mutation, replication with de novo mutations
and degradation, is described as a jump Markov process with the
following state transitions:
W  ?
kR   2W
M  ?
kR   2M
W  ?
km   WzM
W  ?
kd   1
M  ?
kd   1
ð3Þ
The first two transitions reflect replication without mutation, the
third represents de novo mutation, and the last pair represents
degradation. A general formulation of CME is given by: [20]
df x,t x0,t0 j ðÞ
dt
~
X
j
aj x{nj
  
f x{nj,t x0,t0 j
  
{aj x ðÞ f x,t x0,t0 j ðÞ
ð4Þ
where x is the state vector denoting the total number of each
molecular species present in the system and the function
f x,t x0,t0 j ðÞ denotes the probability of a system to assume the
state configuration x at time t, given the initial condition x0 at time
t0. The function aj denotes the propensity function, while nj is the
state change associated with a single j-th event. The propensity
function aj x ðÞ dt gives the probability of the j-th event to occur in
the time interval [t, t+dt). As analytical solution to CME is usually
not available even for moderately sized systems [29], Monte Carlo
algorithms have been employed to solve the CME numerically
[30], e.g. using Gillespie’s SSA (Stochastic Simulation Algorithm)
[31]. In SSA, two random variables (t, j) determine the temporal
evolution of the states in a system, where t is the time for the next
event to occur and j is the type of event that will take place. The
probability density functions of t and j are evaluated based on the
propensity function of the events involved [29].
A modified version of the SSA is used in this work for simulating
in silico mice tissues based on the following CME:
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The density function PW ,M;t ðÞ denotes the probability of a
cell in a given tissue to contain W and M number of wild-type and
mutant mtDNA, respectively, given the initial conditions of the
states (not explicitly stated here for brevity, refer Equation 4). The
parameters kR, kd and km represent the specific probability rate
constants for mtDNA replication, degradation and de-novo point
mutations, respectively. The terms in the curly braces describe the
hypergeometric sampling of mtDNA from the population.
Particularly, the first two terms of the CME above represent
mtDNA replication without mutation, the second pair of terms
corresponds to replication with de-novo mutation, and the last two
terms represent the degradation of mtDNA. The CME can be
solved numerically using a Monte Carlo approach following the
SSA. The implementation of the modified SSA is described below:
1. Compute the propensities of replication and degradation
processes as a function of W and M at time t.
2. Based on the propensities, generate random samples of (t, j)a s
in the SSA algorithm [31].
3. Select ten mtDNA molecules randomly from the population
(hypergeometric sampling) for either replication or degradation
accordingly. Each replication of a wild type mtDNA can result
in a mutant mtDNA with a probability given by the mutation
rate constant (km).
4. Update W and M based on events in steps 2 and 3 and
increment the time t by t.
5. Repeat steps 1 through 4 until the desired end time.
To predict mtDNA mutation burden in a single organ or tissue,
millions of such simulations are performed to capture the mtDNA
dynamics of all cells in a tissue.
(5)
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computing cluster with 112 Intel 1.6 GHz processors. The
simulation code (Text S2) was compiled using GNU FORTRAN
compiler G77 (v4.1.1) and run on a CentOS Linux platform. On
average, a single simulation of a heart tissue (,25 million cells) from
development to 3 years of age required approximately 3 hours.
Simulations of mouse development
The embryonic cell divisions begin after fertilization of an oocyte.
Mouse oocytes harbor a large number of mitochondria (,1.5610
5
mtDNA) [32], which allow the zygote to multiply initially without
the need to replicate mtDNA [33,34]. Mouse embryos with
dysfunctional mitochondrial replication are able to proceed through
the implantation and gastrulation stages, but eventually die,
presumably when the mtDNA synthesis becomes necessary to
maintain ATP level [35,36]. Furthermore, the total mtDNA number
in mouse embryo does not increase until the late stage of blastocyst,
which is roughly the 7
th to 8
th cell divisions in development (i.e., 4.7 to
5.5 days post coitum (d.p.c)) [33,34,37]. During these stages, mtDNA
are segregated among the dividing progenitor cells (Figure 2A).
Consequently, each progenitor cell of the developing embryo has
only few copies of mtDNA at the early egg-cylinder stage [33,34].
In order to account for the mtDNA segregation without
replication during the initial cell divisions, the developmental
simulations start from the end of the 8
th stage (5 d.p.c) with an initial
wild-typemtDNAcountofroughly580moleculespercell(W=580,
M=0) [33]. Mitochondrial DNA replication is tied to the cellular
division to maintain a steady state number of total mtDNA after
each division [38]. Mouse development lasts until 20 d.p.c [39] with
a doubling time of roughly 15.5 hours [40]. The mtDNA
replication rate is estimated assuming that mtDNA doubles its
populationevery15 hourswhilestillundergoingdegradation.Here,
a cell division occurs when the total number of mtDNA count
reaches twice the steady state homeostatic count (Table 1). The
segregation of wild-type and mutant mtDNA between the daughter
cells is assumed to occur at random, withoutanyselective advantage
according to a hypergeometric distribution: [27]
fx ðÞ ~
W
x
  
M
n{x
  
WzM
n
   ð6Þ
where x denotes the number of wild-type mtDNA in one of the
daughter cells after segregation and n is the total number of mtDNA
in a single daughter cell (i.e., n=(W+M)/2). During development,
polymerase-c, the care taker of the mtDNA replication fidelity, is
the main contributor for point mutations in mtDNA, withnegligible
oxidative activity and damage [28,41].
Simulation of postnatal stage
After birth, many tissues like heart do not undergo further
cellular division. However, mtDNA in these tissues are still
continuously turned over independent of cellular division, a
process called ‘‘relaxed replication’’ [26]. The functional signifi-
cance of relaxed replication in postmitotic tissues like heart and
brain is to maintain a healthy population of mtDNA to satisfy the
cellular energy requirements [26,42]. The postmitotic simulations
continue from cells produced at the last stage of development
(Figure 2A), in which each cell maintains mitochondrial biogenesis
to balance degradation. The mutation rate in this stage is a
summation of contributions from oxidative damage and POLG-
related error.
Simulation of POLG mutator mouse models
The in silico mouse model is also used to simulate POLG mutator
heterozygous (POLG
+/mut) and homozygous (POLG
mut/mut)
mice by changing the rate of de novo point mutations. Mutator
mice carry a proofreading-deficient allele of POLG which has 200
times the error rate of the wild-type enzyme [28,43]. Thus, in the
simulations of POLG mutator mice, the model formulation
remains the same in all aspects with the exception that the POLG
error rate corresponding to the mutant allele is assumed to be 200
times higher (Table S2 and S3). In heterozygous POLG mutator
mouse, the replication of mtDNA molecules is carried out by either
wild-type or mutant allele with equal probability.
Model parameters
Model parameters are compiled from published data for mice
and we have ensured that they are consistent with the current
literature and the state of the art techniques. The basic model
parameters are listed in Table 1, while more detailed information
of the rest of parameters used in all mouse models is given in
Tables S1, S2 and S3.
Mitochondrial DNA degradation rate (kd). Cellular
organelles like mitochondria are normally degraded by the
Table 1. Basic model parameters of the in silico stochastic mouse model.
Rates Unit Values Comments References
W0 molecules 580 Initial value of wild type mtDNA during start of development [33,64]
M0 molecules 0 Initial value of mutant mtDNA during start of development
kd d
21 2.3377610
23 Degradation rate of mtDNA [45]
kdev
R molecules d
21 465 Maximum replication rate of mtDNA during development
kdev
m rep
21 bp
21 1.0610
27 Mutation rate of mtDNA during development (POLG fidelity) [28,41,43]
Ncyc - 22 Number of developmental cycles [37,39,40,64]
(W+M)ss molecules 3500 Homeostatic set-point of the mtDNA population (Heart cells) [21,65]
kPM
R molecules d
21 0.8182 Maximum replication rate of mtDNA during post natal stage
kPN
m rep
21 bp
21 1.6610
26 Mutation rate of mtDNA during post natal stage (POLG fidelity and Oxidative burden) [11,28,41,43,54,55]
Ncell - 2.2443610
7 Number of cells (Heart) [21,61]
aPOLG - 200 POLG allele fidelity factor [28,41,43]
doi:10.1371/journal.pcbi.1000572.t001
Stochastic Drift in mtDNA Point Mutations
PLoS Computational Biology | www.ploscompbiol.org 5 November 2009 | Volume 5 | Issue 11 | e1000572autophagy process, where an entire organelle is engulfed by a
lysosome and undergone lytic degradation [44]. The half-life of
mouse mtDNA molecules can be studied in vivo using isotopic
deuterated water
2H20 [45]. The decrease of isotopic
deoxyadenosine in mtDNA after discontinuation of
2H20
treatment can be used to determine the turnover of mtDNA
[45,46], providing a highly sensitive measurement of mtDNA
degradation rate constant for the model, kd.
Hepatocytes of liver are mitotically quiescent and stop
differentiating at the end of the postnatal growth period (,60
days in the rats) [47,48]. While under normal conditions these cells
have a very long life span (,400 days) [48], they can become
mitotic in response to hepatic stress or injury [47,48]. Thus, in
simulating the liver tissue, the slow cellular turnover is approxi-
mated using an elevated mtDNA turnover (Table S2).
Literature values regarding mitochondrial turnover differ
widely, citing half life values ranging from 6 days to ,300 days
[45,46,49–51]. The literature is relatively sparse and spans many
decades. Consequently the methods utilized and the tissues
examined differ significantly among studies, making direct
comparison somewhat difficult. However, considering the higher
value of turnover [49,50], a simple estimation of the expected
mutation load under the simplifying assumptions (refer to Text S1
for details), show that unless there is a preferential degradation of
mutants against the wild-type mtDNA (which at least can be
envisioned for the functionally relevant mtDNA mutations), it is
difficult to see how such high turnover rates can be physiologically
feasible given the low mtDNA mutation frequencies that are
actually found by RMC assay [12] (Figure S6). We also intend to
explore such mechanisms, which are likely to be dependent on the
compartmentalization effects of mitochondria (fusion-fission dy-
namics), retrograde signaling [24] and mitochondrial threshold
levels [52].
Mitochondrial DNA replication rate (kR). The mtDNA
copy number is maintained throughout the cell growth and
divisions [53]. The mtDNA replication should occur to balance
the degradation. There exist evidence supporting the existence of a
retrograde signaling between mitochondria and nucleus to
regulate the mtDNA content based on cellular bioenergetics
[24]. This suggests that mitochondrial biogenesis may be initiated
as soon as the mtDNA copy numbers in a cell falls below a certain
homeostatic set-point value. Here, we have used a constant
biogenesis (i.e. without retrograde signaling), but the main
conclusions of our work remain the same even with retrograde
signaling (see Figure S3 and Text S1). The constant mtDNA
replication rate was deduced based on the homeostatic mtDNA
copy number in a cell and the degradation rate of mtDNA. Thus,
the replication constant kR is given by:
kR~kd WzM ðÞ ss ð7Þ
where WzM ðÞ ss represents the homeostatic level of mtDNA
population in the cell (Table 1).
Mitochondrial DNA point mutation rate (km). In vivo,
8OHdG level most likely ranges from 0.3 to 4.2 lesions per 10
6
bases in nuclear DNA [11,54,55]. However, such lesions make
only about 10 to 20% of the complete damage spectra [12,56].
Therefore, the actual frequency of point mutation rate may be as
low as 1.5 and as high as 42 lesions per 10
6 DNA bases per
replication. In this work, we have made a conservative assumption
that the oxidative damage to mtDNA is the same as that to nuclear
DNA, consistent with our earlier observations [57]. While some
reported values of 8OHdG adducts in mtDNA that are an order of
magnitude higher than in nuclear DNA [10], our simulations
indicate that such a high damage level is unlikely as this will lead to
an mtDNA mutation burden much in excess of those quantified by
RMC assay (Figure S5) [12].
In addition to the oxidative damage, the fidelity of polymerase-
c also contributes to de novo point mutations during replication.
The polymerase is responsible for the replication and proof
reading of newly synthesized strands with a reported error rate
between 1610
27 and 1610
26 bp
21replication
21 for the wild-
type enzyme [28]. Therefore, the overall mutation rate is a sum of
oxidative damage and POLG-related errors, giving a range of
mutation rate between 1.6610
26 and 4.3610
25 mutations per
base pair per mtDNA replication. A conservative value (lowest) of
1.6(10-6 bp-1 replication-1 is chosen for wild-type mouse
simulations.
The summary of all the parameters used in this work is described
in Table S1, S2 and S3. Table S1 gives the details on the model
parameters used for wild-type mouse simulations. Table S2 and S3
give a summary of the model parameters used for simulating the
POLG mutator mice, POLG heterozygous (POLG
+/mut) and
POLG Homozygous (POLG
mut/mut), respectively.
Results/Discussion
Statistical features of the RMC assay
In silico wild-type (WT) mouse population of 1100 individuals
was generated starting from embryo up to three years of age, the
approximate life span of mice (Figure 2). The overall point
mutation frequency in 2.5610
7 cells of whole heart tissues was
recorded at the end of each cell division during development and
every fortnight during the postnatal stage. Figure 3 illustrates the
percentile and distribution function of the mutation frequency
arising from two important sources of variability related to the
quantification of mtDNA point mutations. The probability density
functions indicate the distribution of mutation frequencies in the
population as a function of time. Each contour on the percentile
plot represents the maximum mutation frequency that a given
percentage of the population harbors (e.g. 99% of mice harbor
mutation frequencies up to and including the level indicated by the
99
th percentile curve (Figure 3A, 3C)).
The main source of randomness is the intrinsic stochastic nature
of the aging process, which arises from the mtDNA maintenance
processes (Figure 2B). Note that the intrinsic stochasticity
prevailing in the in silico population has a long tailed non-Gaussian
density function (Figure 3B, 3D), indicating that a small fraction of
the population harbors a significantly higher mutation burden.
Cell-to-cell variability of mtDNA mutation load is also observed as
a result of the random processes (Figure S1). Figure 4 illustrates the
evolution of mtDNA states (W and M) in two cardiomyocytes
during the postnatal stage of a mouse. Random fluctuation of wild-
type mtDNA can be seen in the population with regular bursts and
decay of mutant mtDNA. Furthermore, it is interesting to observe
that despite the significant cell-to-cell variability of mutation load
being large (Figure S1), the average accumulation of mtDNA
mutation in tissue remains linear after birth (Figure 3A). Also, the
variance due to the natural aging process remains roughly
constant during the mouse life span, indicating that the variability
among individuals is inherited at birth.
However, for comparison with data derived from RMC assay, a
second source of variability has to be considered due to the
intrinsic statistical properties of the assay protocol. This is because,
the determination of point mutation burden by the RMC assay
involves drawing a random sample of mtDNA copies (,840,000)
from tissue homogenates [12]. This sampling procedure introduc-
es additional variability that becomes significant due to the low
Stochastic Drift in mtDNA Point Mutations
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the RMC protocol can be described as sampling from a
hypergeometric distribution [27].
fm jWtot,Mtot ðÞ ~
Mtot
m
  
Wtot
n{m
  
WtotzMtot
n
  ð8Þ
where m denotes the number of mutant mtDNA molecules present
in a random sample of mtDNA of size n (n=840,000 mtDNA
molecules in this case). Thus, for low mutation frequencies and
sample sizes, the RMC protocol introduces significant additional
variability in the data. For example, in heart tissue homogenate
containing 10
10 molecules of mtDNA with a mutation frequency
of 10
26/bp (a total of 4610
5 mutant mtDNA), samples of 840,000
mtDNA drawn from the same homogenate will have a mean value
of 3.36 mutants with a standard deviation of 1.83 molecules or
54.6% coefficient of variation from the RMC sampling alone.
The compounded effect of the two sources of variabilities
(intrinsic aging related and RMC assay) can be expressed by,
w m ðÞ ~
X
Wtot,Mtot
fmW tot, j Mtot ðÞ |hW tot,Mtot ðÞ ð 9Þ
where hW tot,Mtot ðÞ denotes the underlying probability distribu-
tion of mtDNA mutations predicted by the mouse model
simulations and w m ðÞ is the overall probability function of measured
mtDNA mutations. Importantly, the additional variability associ-
ated with the sampling of mtDNA in the RMC protocol causes the
mutation frequency variance to increase as a function of the
average mutation frequency (Figure 3C), a result expected from a
hypergeometric distribution. This is particularly relevant here
because of the age-dependent increase in mean mutation burden
and the fact that the distribution describing the mutation process is
long-tailed (Figure 3A, 3B). When this underlying mutation
dynamics is sampled using the RMC assay, the resulting data
will exhibit an age-dependent increase in variance. Due to low
number of replicates (typically n,5 per age group), it is highly
Figure 3. Stochastic determinants of age-dependent dynamics in the observed mtDNA point mutation frequency. Heart tissue
simulations provided the distribution of mutation frequency among 1,100 in-silico wild type mice. (A, B) The percentiles and probability distribution
functions of the mutation frequency arising from the intrinsic stochasticity of cellular processes alone. The dotted line indicates the evolution of the
average mutation frequency of 1,100 mice, which grows linearly with time. (C, D) The percentiles and probability distribution functions of the
mutation frequency in the RMC assay of in silico wild-type mouse population. The apparent variability arises from the combined effect of intrinsic
stochasticity and the (hypergeometric) sampling variability in the RMC protocol (details in the main text).
doi:10.1371/journal.pcbi.1000572.g003
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linear, possibly exponential model (Figure 3C). However, this
apparent exponential increase is not actually a feature of the
underlying mutation dynamics, which may be in fact, linear
(Figure 3A). This has important implications for the interpretation
of the available experimental data.
In accordance with the interpretation reached in the original
experimental work [12], the variance in the in silico data as well as
the experimental data for low n-values appears to suggest an
exponential dynamics supporting the ‘vicious cycle’ theory [3,13].
However, on careful consideration (Figure 3), the apparent
exponential increase of the mutational burden is actually an artifact
of:(a)intrinsicstochasticityofagingprocess(Figure3A,3B),coupled
with(b)therandom sampling variabilityintroduced bythestatistical
properties of the RMC protocol (Figure 3C, 3D). Experimentally, it
is not possible to carry out 100 s or 1000 s of repeats and it is
therefore difficult to distinguish between a truly exponential and a
linear increase of age dependent point mutation burden. In
summary, while the RMC assay is able to quantify extremely low
levels of mutations, its discrete nature (in terms of mutant mtDNA
count) introduces significant challenges in data analysis and
interpretation. The interpretation of the data can be flawed if the
statistical properties of the RMC assay are not considered. Taking
both processes into consideration, the fundamental mtDNA
maintenance processes modeled by our in silico mice are in excellent
agreement with the published data (Figure 3C). However, the last
data point of mutation burden from an old mouse (980 days)
deviated from in silico mouse population (p-value=0.064), suggesting
that other processes not predicted by our model may be involved
during the last months of life (e.g., inflammation or other disorders
that can accelerate oxidative DNA damage [58]).
Transgenic mouse studies
Transgenic mouse studies on POLG mutator mouse have
recently shed some light on the role of mtDNA in aging [8,9,12].
However with these mutator models, many open questions still
remain about the role of mtDNA mutation in aging. For example,
only the homozygous mutator mice exhibited accelerated human-
aging-like phenotypes (e.g., anemia, alopecia, kyphosis) and
shortened lifespan, while the heterozygous mice have no obvious
aging phenotypes, despite significantly elevated mutation burdens
[9].
After successfully validating the in silico mouse model against
wild-type mouse data, we further simulated 1,100 hetero- and
homozygous POLG mouse heart and liver tissues by elevating the
baseline POLG error rate to 200 times that of wild-type [28,43].
We found an excellent agreement of our in silico results with the
reported mutation burdens from two different laboratories [9,12]
(Figure 5 and Figure S4). As with the wild-type mice, the point
mutation increase was linear with age (Figure S4). Again,
mitochondrial turnover and de novo point mutations alone were
sufficient to explain the accumulation of mtDNA point mutations.
These results indicate that even at the elevated levels of point
mutations ROS-mediated acceleration of point mutations with age
is not necessary to explain the data presented in [8,9]. This is
consistent with additional experimental observation suggesting
that the levels of ROS in POLG mice are not significantly elevated
in the mutator mice [8]. Crucially, no modification of mtDNA
Figure 4. Stochastic evolution of mtDNA states. (A) represents
the stochastic evolution of the wild-type mtDNA, while (B) illustrates
the stochastic changes in the mutant mtDNA population. Red and blue
curves indicate the outcomes of two independent realizations.
doi:10.1371/journal.pcbi.1000572.g004
Figure 5. Average mtDNA point mutation frequencies in WT
and POLG mutator mice. The variances in the in silico mouse data
represent the intrinsic stochasticity only (without the RMC sampling
variability).
doi:10.1371/journal.pcbi.1000572.g005
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experimental data [8,9]. That is, one does not have to resort to
assumptions such as the existence of a vicious cycle or other
possible feedback mechanism [59,60].
Significance of development
The stage in an organism’s life from which the accumulation of
mtDNA mutations starts to become functionally significant (if at all)
is unclear. During development, mtDNA replication is tied to the
cellular division, and as a consequence, initial mutations may arise
as soon as mtDNA replication begins. In fact, the total number of
replications during development is comparable to that during the
entire adult life. In mice, the heart tissue develops in about 20 days
[39]. Considering the degradation rate described in Table 1 and the
mouse heart to contain ,2.5610
7 cardiomyocytes [21,61] arising
from 22 cell divisions (6 progenitor cells), the total number of
mtDNA replications needed to maintain homeostatic value of
mtDNA (Table 1) [21] per cell should exceed 9610
10 times during
the development. On the other hand, based on the degradation rate
of mtDNA in postnatal stages (Table 1) [45], the number of mtDNA
replications events over the three years lifespan of mice is about
1.3610
11. Thus depending on their source (ROS, POLG errors),
the development period may carry comparable contributions in de
novo mtDNA mutations as does the entire adult life.
POLG errors havebeenpostulated to be the main cause of de novo
point mutations in murine embryonic fibroblast [28,41]. Therefore,
the POLG baseline error rate was used as mutation rate during
development. Generally, our in silico mouse data highlight that
mutations occurring in the early embryonic cells have a strong
impact on the mutation load at birth (Figure 6) and that the
variability among individuals is set during development (Figure S2
and Figure S4). Since the mtDNA replication is several folds higher
than the degradation during development, de-novo point mutations
generated during the early cell divisions can accumulate very
Figure 6. Mitochondrial DNA point mutation during mouse development. Expansion of mtDNA point mutations during heart tissue
development from in silico wild-type (A), POLG
+/mut (B) and POLG
mut/mut mice (C) population (n=1,100). (A) The square symbols show examples of
point mutation trajectory from two different mice, one of which suffers from a rare point mutation early in the development, resulting in the
amplification of the mutation frequency in subsequent cell divisions. (B) Like in the wild-type cohort, de-novo point mutations generated in the
POLG
+/mut mice during the early cell divisions can accumulate very quickly, resulting in a high mutation load in the cells at birth. (C) Since the error
rate of mtDNA replication in POLG
mut/mut is much higher than the wild-type mtDNA replication, a significant proportion of the population (.75%)
harbors mtDNA mutations at an early stage of development (before the 10
th cell division). As a consequence, the resulting mutation load in the tissue
is significantly higher than that in the wild-type tissues at birth.
doi:10.1371/journal.pcbi.1000572.g006
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individuals (Figure 6). These results highlight that the stochastic
drift of mutation dynamics during the early developmental cell
divisions may be a deciding factor of the organism’s mutation
trajectory, and also a major contributor of the mutation variability
in a population, including isogenetic individuals [19]. The
variability generated during development is conserved throughout
the organism’s life (see Figure 2A and Figure S4A, S4B).
In postmitotic tissues, like heart, mtDNA are continuously
turned over independent of cellular division [26]. Although the
turnover rate of mtDNA is lower during the postnatal stage than
during development, the higher mutation rate due to oxidative
damage (Table 1) can lead to 2–3 fold increase in the mutation
load between birth and old age in wild-type mice (see Figure 2A
and Figure 7). The in silico POLG mice however differ from the
wild-type because in these mice, the POLG error is the dominant
contributor of de novo point mutations, both during embryonic and
postmitotic stages (Supplementary Table S2 and S3). Due to faster
mtDNA replication (tied to cell division), most of the mutations in
mutator mice therefore arise during development (Figure 6B, 6C
and Figure 7). This is consistent with the experimental data which
shows clearly that mutator mice are born with significantly
elevated mutation burden [9,62]. However, during their adult life,
the accumulation is relatively lower compared to their develop-
ment, due to the slow turnover of mtDNA [45].
Furthermore, the above observation leads to an interesting
insight, largely unappreciated in the original work [8,9,63],
regarding the point mutation load in tissues that remain mitotic
(epidermal, stem cells, spleen). Since in POLG mice the point
mutation burden of mtDNA is dominated by POLG errors,
mutation accumulation in fast dividing cells is expected to be
several fold faster than in postmitotic tissues such as heart. This is
consistent with the experimental observation in POLG mutator
mice, where some of the most prominent pathologies associated
with the fast dividing tissues manifest in the form of alopecia,
spleen enlargement and anemia. However it should be appreciated
that such mechanistic hypothesis is speculative, because we have
not included the simulation of mtDNA turnover of any fast
dividing tissues in the present work. Treatment of cell division and
selection pressure for mitochondrial turnover might be a
promising area of investigation for the future work.
Conclusions
By thinkingcarefullyabout the different sources ofstochasticity in
each process from early development all the way to experimental
sampling, we have identified the RMC assay procedure as a major
contributor to the overall uncertainty. In contrast to the original
interpretation of the data, our analysis reveals that the existence of
an exponential dynamics in point mutations cannot be inferred with
certainty, and thus no contradiction between the observed point
mutation dynamics and the apparent absence of evidence for
elevated oxidative stress exists. A detailed, quantitative understand-
ing of the relevant sources of noise also allows optimization of
experimental designs, thereby opening avenues for maximizing
information return and minimizing cost, time and animal use.
The fact that the reproduction of the POLG mouse data requires
no modifications to the wild type model, other than the obvious
decrease of the polymerase fidelity, suggests that elevation of the
point mutation burden does not trigger fundamentally new
processes. In particular, neither mutant replicative advantage nor
theelevationofthe ROSdynamicsresultingfromtheincreaseofthe
point mutation burden is required to explain the POLG data. This
is consistentwithourcurrent view on the mFRTA [4],showing little
evidence for the existence of vicious cycle mechanism. Two further
observations related to the POLG mice that have originally been
seen as somewhat surprising, can also be explained. The first is the
observationthatdividingtissuesseemtobemoreseverelyaffected in
POLG mice than postmitotic tissues [9,63]. The second is the fact
that most mtDNA mutations in the POLG mice are already present
at birth with comparatively little further accumulation during adult
life,whencomparedtoitsdevelopment[9,62].Quantitativeanalysis
shows both of these observations to be consequences of the low
turnover of mtDNA in postmitotic tissues of adult mice.
Finally, our in silico analysis reveals the importance of early
development in determining the trajectory of mtDNA mutation
burden. This is in sharp contrast to the common assumption that
health and diseases are determined predominantly by the genome
interacting with the environment. Here, we have demonstrated
that in silico modeling can contribute significantly to analysis and
understanding of experimental data as well as potentially help to
design more effective methodology. We believe that this approach
of ‘‘Computer Aided Thought’’ can contribute towards a
fundamentally improved understanding of intrinsically challenging
biological problems such as aging.
Supporting Information
Figure S1 Point mutation distribution in cells of heart tissue from
different in silico mice. Stacked distribution plots of the normal and
mutant mtDNA counts (W,M) in an in silico mouse heart. Each plot
represents the simulation outcome of a single heart tissue. Subplots
on the left pane represent the complete distribution of all states in
the cells and those on the right pane illustrate the states distribution
for all the cells having at least one mutant mtDNA (M.0) (Note,the
frequency of the cells having mutant mtDNA in a wild-type tissue is
two orders of magnitude lower than the cells from the tissue of
POLG mutator mice). Dispersion of mutation load in the cells has
an increasing trend amongst the three different mouse models with
the POLG
mut/mut mouse having the highest dispersion of mutant
mtDNA states in the cells. The stochastic nature of mtDNA
Figure 7. Average mtDNA point mutation accumulation in wild
type and POLG mutator mouse models. Wild-type mice have a low
mutation burden at birth, but they accumulate relatively more
mutations during their life. On the other hand, the POLG mice harbor
a significant mutation load at birth due to error-prone mtDNA
replications during development. In the post-mitotic stage however,
the relative accumulation (in comparison to mutations at the birth) is
significantly lower due to the slow turnover of mtDNA.
doi:10.1371/journal.pcbi.1000572.g007
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dispersion. (A, B) Distribution of mtDNA states in the tissue of
wild-type mouse. (C, D) Distribution of the mtDNA states in the
tissueofPOLG
+/mut (heterozygous)mouse.(E,F)Distributionofthe
mtDNA states in the tissue of POLG
mut/mut (homozygous) mouse.
Found at: doi:10.1371/journal.pcbi.1000572.s001 (1.84 MB TIF)
Figure S2 Simulations with exclusion of developmental phase.
Sources of variability in the observed mtDNA point mutation
frequency of 1,100 in silico wild-type mouse heart tissues without
developmental de novo point mutations. The mutation frequencies
were recorded every fortnight up to 36 months. (A) The percentile
curve of mutation frequency due to the intrinsic stochasticity of
aging process in the mouse population. The mtDNA maintenance
during life did not cause any observable variability among the
mouse population, as indicated by the overlapping percentile
curves and the sharp distribution. This is in agreement with our
previous observation that the genetic variability is inherited from
the development and conserved during the adult life. (B) The
percentile curve of the mutation frequency in the RMC assay of in
silico wild-type mouse population. The variability again increases
with age due to the increase of the mutation frequency. The model
excluding the development was in worse agreement with the
experimental data than the trials that included the development
(Figure 3 in Main Text). (C) Comparison of the average mutation
frequency in mouse heart tissues with and without developmental
contribution. Two types of simulations were performed, one type
included de novo mutations during development while the other did
not (i.e. no mutations at birth). Although the influence of
development in the wild-type mice is rather insignificant at older
ages, the exclusion of the developmental stage in the simulations of
the POLG mutator mice causes a significant difference in the
resulting mutation burden. The variance in the in silico mice data
represents the intrinsic genetic variability only, without the RMC
sampling variability.
Found at: doi:10.1371/journal.pcbi.1000572.s002 (1.14 MB TIF)
Figure S3 Effect of different choices of point mutation model on
the average mutation burden. The average mutation frequency
reported in the plot represents the mutation burden in the heart
tissues of wild-type mice and was recorded at the end of 36
months. (a) Comparison of the average mutation burden obtained
using two different turnover rates. The higher turnover rate was
based on a frequently cited experimental data (a half-life of 17 days
reported by [1,2] in the figure). It is evident that usage of such high
value of turnover can give vastly differing mutation loads and the
model is particularly very sensitive with respect to the turnover
rates. Also Supplementary Figure S6 further illustrates the
variation of the point mutation burden in population of 100 mice
for this turnover rate. (b) Comparison of the average mutation
burden obtained using two different replication models described
in the supplementary text. The two replication models based on: (i)
constant biogenesis, and (ii) biogenesis with the Hill-type kinetics
are equivalent.
Found at: doi:10.1371/journal.pcbi.1000572.s003 (1.29 MB TIF)
Figure S4 Stochastic determinants of age-dependent point
mutation dynamics in mutator mice. Comparison of the observed
mtDNA point mutation frequency in a population of 1,100 in silico
POLG mouse heart tissues (Heterozygous and Homozygous). The
mutation frequencies were recorded every fortnight up to 36
months (heterozygous) and 14 months (homozygous). (A) The
percentile curves of the mutation frequency in the RMC assay of in
silico POLG
+/mut mouse (heterozygous) population. The apparent
variability arises from the genetic variations intrinsic to the aging
process and the hypergeometric sampling variability in the RMC
protocol (details in the Methods section). (B) The percentile
curves of the mutation frequency in the RMC assay of in silico
POLG
mut/mut mouse (homozygous) population. Unlike the wild-
type, the uncertainty arising due to the combined effect of the two
sources of variability does not increase with time. The variance
remains roughly constant with age and this is primarily due to the
high point mutation load prevailing in the cells at birth, which only
increases relatively marginally with age.
Found at: doi:10.1371/journal.pcbi.1000572.s004 (0.50 MB TIF)
Figure S5 Mitochondrial DNA point mutation burden under an
elevated oxidative burden assumption. The oxidative burden used
in these simulations was elevated to 10 times higher than that used
in the main article (Figure 3 in Main Text). The mutation
frequencies were again recorded every fortnight up to 36 months.
(A, B) The percentile curve and distribution of the mutation
frequency due to the intrinsic stochasticity of aging process in the
mouse population (n=500 mice). (C, D) The percentile curve and
distribution of the mutation frequency estimated by the RMC
assay of the in silico wild-type mouse population considered.
Found at: doi:10.1371/journal.pcbi.1000572.s005 (1.12 MB TIF)
Figure S6 Mitochondrial DNA point mutation burden simulat-
ed using mtDNA half-life of 17 days. Inherent mtDNA point
mutation frequency in the heart tissues of 100 mice using an
mtDNA half life of 17 days (based on the references [2] and [3]
indicated in the figure). The mutation frequencies in the post
development were monitored every fortnight up to 36 months. (A)
Expansion of the mtDNA point mutations during the heart tissue
development and, (B) Point mutation dynamics in the mouse
population post-birth.
Found at: doi:10.1371/journal.pcbi.1000572.s006 (1.23 MB TIF)
Table S1 Model parameters used in the simulations of the in
silico wild-type mice.
Found at: doi:10.1371/journal.pcbi.1000572.s007 (0.07 MB
DOC)
Table S2 Model parameters used in the simulations of the in
silico POLG heterozygous mice’s (POLG
+/mut) mice.
Found at: doi:10.1371/journal.pcbi.1000572.s008 (0.09 MB
DOC)
Table S3 Model parameters used in the simulations of the in
silico POLG homozygous mice’s (POLG
mut/mut) mice.
Found at: doi:10.1371/journal.pcbi.1000572.s009 (0.07 MB
DOC)
Text S1 Supporting Information
Found at: doi:10.1371/journal.pcbi.1000572.s010 (0.07 MB
DOC)
Text S2 Stochastic mtDNA Point Mutation Simulation
Algorithm
Found at: doi:10.1371/journal.pcbi.1000572.s011 (0.03 MB PDF)
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